Thyrocare Technologies Limited (NSE: THYROCARE), ISIN INE594H01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
THYROCARE last traded at ₹579.75 (-0.02%), with a 52-week range of ₹342.55 to ₹617.30 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 60.92%, FIIs 5.44%, DIIs 20.92%, mutual funds 19.86%.
EquiSense Score (ECS): 83/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.